...
首页> 外文期刊>Trends in Ecology & Evolution >HDQLIFE and Neuro-QoL Physical Function Measures: Responsiveness in Persons With Huntington's Disease
【24h】

HDQLIFE and Neuro-QoL Physical Function Measures: Responsiveness in Persons With Huntington's Disease

机译:HDQLIFE和神经QOL物理功能措施:亨廷顿疾病人员的响应性

获取原文
获取原文并翻译 | 示例

摘要

Background Huntington's disease (HD) is a neurological disorder that causes severe motor symptoms that adversely impact health-related quality of life. Patient-reported physical function outcome measures in HD have shown cross-sectional evidence of validity, but responsiveness has not yet been assessed. Objectives This study evaluates the responsiveness of the Huntington Disease Health-Related Quality of Life (HDQLIFE) and the Quality of Life in Neurological Disorders (Neuro-QoL) physical function measures in persons with HD. Methods A total of 347 participants completed baseline and at least 1 follow-up (12-month and 24-month) measure (HDQLIFE Chorea, HDQLIFE Swallowing Difficulties, HDQLIFE Speech Difficulties, Neuro-QoL Upper Extremity Function, and/or Neuro-QoL Lower Extremity Function). Of the participants that completed the baseline assessment, 338 (90.9%) completed the 12-month assessment, and 293 (78.8%) completed the 24-month assessment. Standardized response means and general linear models evaluated whether the physical function measures were responsive to self-reported and clinician-rated change over time. Results Small to moderate effect sizes for the standardized response means supported 12-month and 24-month responsiveness of the HDQLIFE and Neuro-QoL measures for those with either self-reported or clinician-rated declines in function. General linear models supported 12-month and 24-month responsiveness for all HRQOL measures relative to self-reported declines in health, but generally only 24-month responsiveness was supported relative to clinician-rated declines in function. Conclusions Longitudinal analyses indicate that the HDQLIFE and the Neuro-QoL physical function measures are sensitive to change over time in individuals with HD. Thus, these scales exhibit evidence of responsiveness and may be useful outcome measures in future clinical trials. (c) 2019 International Parkinson and Movement Disorder Society
机译:背景技术亨廷顿的疾病(HD)是一种神经系统疾病,导致严重的运动症状产生与健康相关的生活质量产生不利影响。患者报告的HD中的物理功能结果措施显示有效性的横断面证据,但尚未评估响应能力。目的这项研究评估了亨廷顿疾病与健康状生活质量(HDQLIFE)和神经障碍的生活质量(神经QOL)物理功能措施的响应能力在HD的人中。方法共有347名参与者完成基线,至少1次跟进(12个月和24个月)措施(HDQLIFE Chorea,HDQLife吞咽困难,HDQLIFE语音困难,神经QOL上肢功能和/或神经QOL下肢功能)。在完成基线评估的参与者的内容中,338名(90.9%)完成了12个月的评估,293(78.8%)完成了24个月的评估。标准化响应装置和一般线性模型评估了物理功能措施是否随着时间的推移对自我报告和临床医生额定变化进行响应。结果对于标准化响应的适度效应尺寸很小,而且支持的HDQLIFE和Neuro-QOL措施的24个月响应性,为自我报告的或临床医生的功能下降。一般线性模型支持12个月和24个月对所有HRQOL措施相对于自我报告的健康下降措施的响应性,但一般只有24个月的响应能力,相对于临床医生额定的功能下降。结论纵向分析表明,HDQLIFE和神经QOL物理功能措施对HD个体中的个体随时间变化敏感。因此,这些尺度表现出反应性的证据,并且可能是未来临床试验中有用的结果措施。 (c)2019国际帕金森和运动障碍协会

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号